Syntekabio USA
Provider of AI-driven drug discovery services and computational biology platforms. Offers large-scale virtual screening, physics-based molecular docking, computational antibody and neoantigen discovery, and end-to-end discovery support from hit finding through IND-enabling activities. Maintains high-performance compute infrastructure and claims validation via external collaborations and benchmark comparisons.
Industries
N/A
Products
Language-model-based virtual screening service
High-throughput virtual screening service that applies language-model approaches to prioritize billions of compounds for a given target.
Automated binding-pose prediction and flexible docking tools
Computational docking toolset for binding-pose prediction and flexible docking with benchmarked performance for pose accuracy.
Automated lead generation and optimization workflows
Algorithmic workflows that propose and optimize lead compounds to improve potency and developability.
Computational biologics discovery and neoantigen prediction services
In silico antibody and neoantigen identification services coupled with peptide synthesis and immunoassay validation workflows.
Language-model-based virtual screening service
High-throughput virtual screening service that applies language-model approaches to prioritize billions of compounds for a given target.
Automated binding-pose prediction and flexible docking tools
Computational docking toolset for binding-pose prediction and flexible docking with benchmarked performance for pose accuracy.
Automated lead generation and optimization workflows
Algorithmic workflows that propose and optimize lead compounds to improve potency and developability.
Computational biologics discovery and neoantigen prediction services
In silico antibody and neoantigen identification services coupled with peptide synthesis and immunoassay validation workflows.
Services
Develop Now, Pay Later program
Programmatic offering that funds initial computational discovery and feasibility work so clients can evaluate targets without upfront costs.
STB LaunchPad — end-to-end discovery program
Integrated discovery program intended to deliver hits, optimized leads and IND-enabled candidates through combined computational and experimental workflows.
Complimentary target feasibility study
Rapid feasibility analysis of a client-provided protein target to determine tractability before committing to a full discovery program.
Develop Now, Pay Later program
Programmatic offering that funds initial computational discovery and feasibility work so clients can evaluate targets without upfront costs.
STB LaunchPad — end-to-end discovery program
Integrated discovery program intended to deliver hits, optimized leads and IND-enabled candidates through combined computational and experimental workflows.
Complimentary target feasibility study
Rapid feasibility analysis of a client-provided protein target to determine tractability before committing to a full discovery program.
Expertise Areas
- AI-driven virtual screening
- Physics-based molecular docking
- Computational antibody discovery
- Neoantigen prediction for immuno-oncology
Key Technologies
- Language-model-based virtual screening
- Flexible molecular docking
- AI-driven lead optimization algorithms
- Computational antibody design